KAILEY DAVIS: Open Payments
NPI 1093195729 · WETUMPKA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$744 in 35 payments from 11 companies in 2025. Trend: 2023 $560 · 2024 $609 · 2025 $744
Food & beverage: $744
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $165 |
| Otsuka America Pharmaceutical, Inc. | 5 | $124 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $120 |
| AstraZeneca Pharmaceuticals LP | 4 | $88 |
| Axsome Therapeutics, Inc. | 2 | $59 |
| Lundbeck LLC | 2 | $48 |
| INTUITIVE SURGICAL, INC. | 1 | $45 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $35 |
| Novo Nordisk Inc | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
Products named: REXULTI, VRAYLAR, CAPLYTA, Auvelity, AIRSUPRA, Da Vinci Surgical System, BREZTRI, XIFAXAN.
Industry payments across AL — which companies pay providers there.
